Methoxsalen - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for methoxsalen and what is the scope of patent protection?
Methoxsalen
is the generic ingredient in five branded drugs marketed by Valeant Pharm Intl, Actavis Inc, Ani Pharms, Strides Pharma, Bausch, and Mallinckrodt Hosp, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.There are seven drug master file entries for methoxsalen. Two suppliers are listed for this compound.
Summary for methoxsalen
US Patents: | 0 |
Tradenames: | 5 |
Applicants: | 6 |
NDAs: | 6 |
Drug Master File Entries: | 7 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 150 |
Clinical Trials: | 25 |
Patent Applications: | 6,184 |
Drug Prices: | Drug price trends for methoxsalen |
What excipients (inactive ingredients) are in methoxsalen? | methoxsalen excipients list |
DailyMed Link: | methoxsalen at DailyMed |
Recent Clinical Trials for methoxsalen
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Georgetown University | Phase 2 |
European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 |
Joseph Ahmed Foundation | Phase 2 |
Pharmacology for methoxsalen
Drug Class | Photoactivated Radical Generator Psoralen |
Mechanism of Action | Photoabsorption |
Physiological Effect | Photosensitizing Activity |
Medical Subject Heading (MeSH) Categories for methoxsalen
Anatomical Therapeutic Chemical (ATC) Classes for methoxsalen
US Patents and Regulatory Information for methoxsalen
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Inc | METHOXSALEN | methoxsalen | CAPSULE;ORAL | 202603-001 | Jun 9, 2015 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Mallinckrodt Hosp | UVADEX | methoxsalen | INJECTABLE;INJECTION | 020969-001 | Feb 25, 1999 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Valeant Pharm Intl | OXSORALEN | methoxsalen | LOTION;TOPICAL | 009048-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ani Pharms | METHOXSALEN | methoxsalen | CAPSULE;ORAL | 087781-001 | Jun 8, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Valeant Pharm Intl | 8-MOP | methoxsalen | CAPSULE;ORAL | 009048-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for methoxsalen
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mallinckrodt Hosp | UVADEX | methoxsalen | INJECTABLE;INJECTION | 020969-001 | Feb 25, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Bausch | OXSORALEN-ULTRA | methoxsalen | CAPSULE;ORAL | 019600-001 | Oct 30, 1986 | ⤷ Sign Up | ⤷ Sign Up |
Mallinckrodt Hosp | UVADEX | methoxsalen | INJECTABLE;INJECTION | 020969-001 | Feb 25, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Mallinckrodt Hosp | UVADEX | methoxsalen | INJECTABLE;INJECTION | 020969-001 | Feb 25, 1999 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.